60 likes | 74 Views
Pomahope 4mg is a Glenmark Pharmaceuticals product which is endorsed by FDA, containing an active anti-cancer drug called Pomalidomide, It is available as orally bioavailable thalidomide derivative with various therapeutic activities such as;Immuno modulatory, Anti-angiogenesis, Anti-neoplastic
E N D
APPLEPHARMACEUTICALS Is a fully licensed and regulated pharmacy, takes all precautions to strictly abide by the laws and regulations set forth in the dispensing of prescription medications. By placing the order for your prescription medicines, you acknowledge and accept the following terms regarding the purchase of any prescription medicines.
POMALIDOMIDE POMAHOPE 4MG
DESCRIPTION Pomahope 4mg is a Natco pharma product which is endorsed by FDA, containing an active anti-cancer drug called Pomalidomide. Pomahope 4mg is available as orally bioavailable thalidomide derivative with various therapeutic activities such as; Immuno modulatory Anti-angiogenesis Anti-neoplastic Pomahope 4mg is similar to thalidomide & Lenalidomide with related to decreased rate of serum aminotransferase elevations during treatment. This may leads to severe liver injury. Pomahope 4mg is involved in the treatment for regression & unmanageable multiple myeloma. Pomahope 4mg is used in the patients who are failing to response for Lenalidomide treatment. Pomahope 4mg is used in combination with dexamethasone. • INDICATION • The major therapeutic indication of Pomahope 4mg is involved in the treatment of multiple myeloma. • This treatment is occurred by combining with dexamethasone for reducing the side effect associated with Pomahope4mg. Pomahope4mg is majorly indicated in patients who are not reacts for prior two therapies like Lenalidomide & proteasome inhibitor.
POMALID WORKS Pomahope 4mg exhibits various activities like; Anti-neoplastic activity Prohibits proliferation Promote apoptosis of hematopoietic cancer cells Co adjuvant with dexamethasone in both Lenalidomide sensitive & resistant myeloma cells to activate the tumor cell apoptosis Immuno modulatory Boosted the T-cells & natural killer cell mediate immunity. The drug is prohibited the formation of pro-inflammatory cytokines by monocytes. Anti-angiogenesis Interfere with formation of new vessels and leads to inhibit the cell division.
DRUG INTERACTION • Pomalidomide metabolism is mediated by CYP1A2 & CYP3A4. The concomitant use of Pomahope 4mg with CYP1A2 drugs like Fluoxamine causes elevation of Cmax & AUC of Pomalidomide and concludes as increased concentration of Pomahope leads to higher extent of adverse effects associated with Pomahope In this condition, reduce the dose of Pomahope 4mg and recommended. • STORAGE • Pomahope 4mg should be stored at room temperature of 20° to 25° Protect from light Kept in dry & cool place
CALL CONTACT US • +919987711567 • MAIL VISIT US • applepharamaceutical@gmail.com • https://myapplepharama.com/ • ADDRESS Apartment No.304 A Wing, Shiva Shakthichs ltd, JP Road, Near Apna Bazar,Andheri(West), Mumbai - 400058.